MHNR Network, LLC

Mental Health News Radio

Mental Health News Radio

  • The Need for a New Approach in Treating Psychiatric Disease

The Need for a New Approach in Treating Psychiatric Disease

Tuesday 26th February 2019

Join Kristen Sinanta-Walker as she chats with Thomas Kim about EpiVario's groundbreaking approach to treating psychiatric disorders.
28 minutes
Informative
Hopeful
Compassionate
Educational
Supportive

About this podcast

Mental Health News Radio
Author:
MHNR Network, LLC
Overview:
Categories:
Body & Mind
Healing Relationships
Sobriety Toolkit
Healing from Sexual Trauma
Innovative Treatments & Recovery Paths
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Revolutionising Psychiatric Treatment: A Chat with EpiVario's CEO

Episode Overview

  • EpiVario is developing drugs to treat memory-related psychiatric disorders.
  • The approach targets genetic pathways involved in memory formation.
  • Potential to reduce therapy dropout rates and prevent relapses.
  • Aims to lessen traumatic memory intensity and support psychotherapy.
  • Research is in early stages, backed by significant seed funding.
What we're trying to do is not manipulate existing memories... but inhibit a genetic gene expression process.
In a captivating episode of Mental Health News Radio, host Kristen Sinanta-Walker dives into the complexities of treating psychiatric diseases with Thomas Kim, CEO of EpiVario. EpiVario is pioneering a fresh approach to tackling memory-related psychiatric disorders like PTSD, Alzheimer's, and addiction by targeting genetic pathways involved in memory formation. Thomas shares the company's journey, highlighting the innovative drug development process that aims to lessen the intensity of traumatic memories and enhance the effectiveness of psychotherapy.
The conversation is candid and informative, as Thomas discusses the challenges and hopes associated with developing a new medication in a field often overshadowed by stigma. He passionately explains how their research could potentially reduce dropout rates in therapy and prevent relapses by addressing the root causes of these disorders.
With humour and empathy, Kristen navigates the interview, drawing parallels between the proposed drug and existing therapies like EMDR, while ensuring clarity on the drug's role as an adjunct to psychotherapy. This episode is a must-listen for anyone interested in mental health advancements and those curious about the future of psychiatric treatment. It offers a unique perspective on how science is striving to improve lives by tackling complex mental health issues at their core.
Don't miss out on this enlightening conversation that might just change your view on mental health treatment.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.